Botulinum toxin a for axillary hyperhidrosis (excessive sweating).

被引:264
作者
Heckmann, M
Ceballos-Baumann, AO
Plewig, G
机构
[1] Univ Munich, Dermatol Klin, Dept Dermatol, D-80337 Munich, Germany
[2] Tech Univ Munich, Dept Neurol, D-8000 Munich, Germany
关键词
D O I
10.1056/NEJM200102153440704
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Treatment of primary focal hyperhidrosis is often unsatisfactory. Botulinum toxin A can stop excessive sweating by blocking the release of acetylcholine, which mediates sympathetic neurotransmission in the sweat glands. Methods: We conducted a multicenter trial of botulinum toxin A in 145 patients with axillary hyperhidrosis. The patients had rates of sweat production greater than 50 mg per minute and had had primary axillary hyperhidrosis that was unresponsive to topical therapy with aluminum chloride for more than one year. In each patient, botulinum toxin A (200 U) was injected into one axilla, and placebo was injected into the other in a randomized, double-blind manner. (The units of the botulinum toxin A preparation used in this study are not identical to those of other preparations.) Two weeks later, after the treatments were revealed, the axilla that had received placebo was injected with 100 U of botulinum toxin A. Changes in the rates of sweat production were measured by gravimetry. Results: At base line, the mean (+/-SD) rate of sweat production was 192+/-136 mg per minute. Two weeks after the first injections the mean rate of sweat production in the axilla that received botulinum toxin A was 24+/-27 mg per minute, as compared with 144+/-113 mg per minute in the axilla that received placebo (P<0.001). Injection of 100 U into the axilla that had been treated with placebo reduced the mean rate of sweat production in that axilla to 32+/-39 mg per minute (P<0.001). Twenty-four weeks after the injection of 100 U, the rates of sweat production (in the 136 patients in whom the rates were measured at that time) were still lower than base-line values, at 67+/-66 mg per minute in the axilla that received 200 U and 65+/-64 mg per minute in the axilla that received placebo and 100 U of the toxin. Treatment was well tolerated; 98 percent of the patients said they would recommend this therapy to others. Conclusions: Intradermal injection of botulinum toxin A is an effective and safe therapy for severe axillary hyperhidrosis. (N Engl J Med 2001;344:488-93.) Copyright (C) 2001 Massachusetts Medical Society.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 38 条
[1]  
Brisinda G, 1999, NEW ENGL J MED, V341, P624
[2]   Botulinum toxin - A possible new treatment for axillary hyperhidrosis [J].
Bushara, KO ;
Park, DM ;
Jones, JC ;
Schutta, HS .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1996, 21 (04) :276-278
[3]   ENDOSCOPIC TRANSTHORACIC ELECTROCAUTERY OF THE SYMPATHETIC CHAIN FOR PALMAR AND AXILLARY HYPERHIDROSIS [J].
BYRNE, J ;
WALSH, TN ;
HEDERMAN, WP .
BRITISH JOURNAL OF SURGERY, 1990, 77 (09) :1046-1049
[4]   Functional repair of motor endplates after botulinum neurotoxin type A poisoning:: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals [J].
de Paiva, A ;
Meunier, FA ;
Molgó, J ;
Aoki, KR ;
Dolly, JO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3200-3205
[5]   Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle [J].
Dressler, D ;
Rothwell, JC .
EUROPEAN NEUROLOGY, 2000, 43 (01) :13-16
[6]   FREYS-SYNDROME - TREATMENT WITH BOTULINUM TOXIN [J].
DROBIK, C ;
LASKAWI, R .
ACTA OTO-LARYNGOLOGICA, 1995, 115 (03) :459-461
[7]   SYSTEMIC EFFECT OF LOCAL BOTULINUM TOXIN INJECTIONS UNMASKS SUBCLINICAL LAMBERT-EATON MYASTHENIC SYNDROME [J].
ERBGUTH, F ;
CLAUS, D ;
ENGELHARDT, A ;
DRESSLER, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (11) :1235-1236
[8]  
FREEMAN R, 1990, DERMATOL CLIN, V8, P479
[9]   Botulinum A neurotoxin for axillary hyperhidrosis - No sweat botox [J].
Glogau, RG .
DERMATOLOGIC SURGERY, 1998, 24 (08) :817-819
[10]   BOTULINUM TOXIN-A FOR SPASTICITY, MUSCLE SPASMS, AND RIGIDITY [J].
GRAZKO, MA ;
POLO, KB ;
JABBARI, B .
NEUROLOGY, 1995, 45 (04) :712-717